Carnival Corporation Update on Operations

Carnival Corporation Update on Operations

For Carnival Corporation and our nine world-leading cruise line brands, our highest responsibility and top priorities are compliance, environmental protection and the health, safety and well-being of our guests, crew and the communities we visit. Below is an update on cruise operations.

An Industrywide Approach

The Cruise Line Industry Association (CLIA) – with input from Carnival Corporation and our cruise line brands and fellow members – announced on Sept. 21 the adoption of a strong set of health protocols that represent core elements for returning to service in the Americas.

These core elements are applicable to CLIA member ocean-going cruise ships subject to the U.S. Centers for Disease Control and Prevention’s (CDC) No Sail Order in the U.S. and will be continuously evaluated and adjusted against the current state of the COVID-19 pandemic, as well as the availability of new prevention, therapeutics and mitigation measures.

Highlights include:

  • Testing: 100% testing of passengers and crew for COVID-19 prior to embarkation.
  • Mask-Wearing: Mandatory wearing of masks by all passengers and crew onboard and during excursions whenever physical distancing cannot be maintained.
  • Distancing: Physical distancing in terminals, onboard ships, on private islands and during shore excursions.
  • Ventilation: Air management and ventilation strategies to increase fresh air onboard and, where feasible, using enhanced filters and other technologies to mitigate risk.
  • Medical Capability: Risk-based response plans tailored for each ship to manage medical needs, dedicated cabin capacity allocated for isolation and other operational measures, and advance arrangements with private providers for shoreside quarantine, medical facilities and transportation.
  • Shore Excursions: Only permit shore excursions according to the cruise operators’ prescribed protocols, with strict adherence required of all passengers and denial of re-boarding for any passengers that do not comply.

 
Carnival Corporation’s CruiseHealth Program

  • As our cruise line brands gradually resume cruising, our commitment to the health, safety and well-being of our guests, crew and communities we visit is reflected in our enhanced health measures developed in conjunction with government health authorities, public health experts, local ports and CLIA.
  • As our understanding of COVID-19 is still evolving, we are working closely with some of the best minds in medical science, public health and infectious disease control to understand the challenges posed by the virus and how best to mitigate its spread.
  • Our CruiseHealth program elevates our existing practices to even greater levels to give consumers confidence and peace of mind when going on a cruise vacation with us.
  • Our operational protocols are being designed to be flexible and responsive to quickly adapt to the latest learnings as necessary. 
  • One of Carnival Corporation’s nine cruise line brands – Italy-based Costa Cruises – restarted sailings in September in Europe, and Germany-based AIDA Cruises restarted sailings in October. The enhanced health and safety protocols in place for AIDA and Costa have been developed in coordination with medical and scientific experts, and national and global authorities.

CruiseHealth Program Enhancements and Protocols Being Contemplated

  1. Health Screening, Illness Surveillance and Health Education
    • All guests and crew embarking a ship will undergo enhanced pre-embarkation health screening in accordance with prevailing health best practices, such as health questionnaires and touch-free temperature checks as appropriate
    • Those identified at risk will undergo additional health evaluation by medical staff
    • Health checks as appropriate during the cruise for guests and crew
    • Rapid response and contact tracing plans in case of on-board illness
       
  2. Environmental Sanitization
    • Routinely use a safe disinfectant proven to quickly kill novel coronaviruses
    • Staterooms and public areas sanitized more frequently with cleaning and disinfection protocols developed in coordination with the U.S. Centers for Disease Control & Prevention (CDC)
    • Ships and terminals undergo more thorough sanitization between cruises
    • Expanded disinfection methods using emerging and advanced technologies that are proven effective against coronavirus and other germs
       
  3. Guest Experience
    • Responsible physical distancing managed by adjusting the flow, timing and size of groups
    • Hand Hygiene – Additional handwashing facilities and hand sanitizing stations positioned in high-traffic areas throughout the ship 
    • Health Information – providing regular health reminders about the ways to stay healthy onboard and when ashore
  1. Health Care
    • A team of highly trained medical staff including qualified doctors and nurses who have experience in caring for a broad range of medical conditions
    • Medical centers that have both outpatient and inpatient facilities including critical care capabilities 
    • Medical centers modified for infection control best practices including dedicated air handling systems with 100% fresh air supply and HEPA exhaust filtration
    • Medication onboard that improves COVID-19 clinical outcomes
    • COVID-19 testing capabilities onboard and/or ashore with designated laboratories for potential cases onboard
    • Dedicated isolation and quarantine rooms should they be needed
    • Ongoing training and education of medical staff in the latest clinical care practices for managing COVID-19 cases
    • Partnerships with local and regional medical providers
    • Trained onboard staff to monitor compliance with health measures
    • Training of all crew in COVID-19 health protocols
       
  2. Ventilation Systems
    • Enhanced fresh air distribution into public spaces and staterooms
    • HEPA filtration systems to key areas such as medical centers and dedicated isolation rooms
       
  3. Partnerships with Local Stakeholders
    • Working with local health authorities, destinations and other key stakeholders to ensure alignment on our enhanced health measures
    • Monitor disease activity and health regulations in the destinations we visit and adjust the itinerary as necessary

 

For the latest updates on cruise operations from our nine world-leading cruise line brands, please visit the brand homepages at the links below.

07-AIDA_1.png
https://aida.de/
Cruiseline
https://www.carnival.com/
Costa
https://www.costacruises.com/
Cunard
https://www.cunard.com/
Holland America Line
https://www.hollandamerica.com/
P&O
https://www.pocruises.com/
P&O
https://www.pocruises.com/
Princess
https://www.princess.com/
Seabourn
https://www.seabourn.com/


Health Advisors Supporting Enhanced Protocols
We have been working with a number of world-leading public health, epidemiological and policy experts to support our ongoing efforts for developing enhanced protocols and procedures for the return of cruise vacations based on the latest knowledge around protection and mitigation.

The advisors include:

  • Dr. Vivek Murthy, MD, MBA, author, former vice admiral in the Public Health Service Commissioned Corps and 19th Surgeon General of the United States
  • Dr. Simon Clarke, associate professor in cellular microbiology, University of Reading School of Biological Sciences (UK)
  • Michael S. Diamond, MD, PhD, Herbert S. Gasser professor of medicine, molecular microbiology, pathology & immunology; and associate director, Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine in St. Louis
  • Michael Z. Lin, MD, PhD, associate professor of neurobiology, bioengineering, and chemical and systems biology; and principal investigator, The Lin Lab, Stanford University School of Medicine
  • Dr. Jewel Mullen, MD, MPH, associate dean for health equity, University of Texas at Austin, Dell Medical School
  • Emil C. Reisinger, MD, full professor of internal medicine, infectious diseases and tropical medicine and director of the Division of Tropical Medicine and Infectious Diseases, Department of Internal Medicine, University of Rostock, Germany
  • Dr. Stefano Vella, MD, former director, National Center for Global Health, Istituto Superiore di Sanità (Italian National Institute of Health); and adjunct professor of global health, Università Cattolica del Sacro Cuore (Catholic University of the Sacred Heart) in Rome